Search

everythinglearnresearchcommunity

for

Search:↓

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

New cytokine-targeted therapies show promise for treating alopecia areata.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

New treatments focusing on immune pathways show promise for stubborn hair loss.